W P Sheridan Selected Research

Testosterone (Sustanon)

1/2000

Development of GnRH antagonists for prostate cancer: new approaches to treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W P Sheridan Research Topics

Disease

2	Hereditary Angioedemas 09/2018 - 12/2016
1	Angioedema 09/2018
1	Eczema 12/2016
1	Syncope (Fainting) 12/2016
1	Abdominal Pain (Pain, Abdominal) 12/2016
1	Back Pain (Backache) 12/2016
1	Human Influenza (Influenza) 02/2011
1	Disease Progression 01/2000
1	Prostatic Neoplasms (Prostate Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

2	avoralstatIBA 09/2018 - 12/2016
2	Plasma KallikreinIBA 09/2018 - 12/2016
1	Kallikreins (Kallikrein)IBA 09/2018
1	Antiviral Agents (Antivirals)IBA 02/2011
1	Neuraminidase (Sialidase)IBA 02/2011
1	peramivirIBA 02/2011
1	Dihydrotestosterone (Androstanolone)IBA 01/2000
1	Testosterone (Sustanon)FDA Link 01/2000
1	Leuprolide (Lupron)FDA LinkGeneric 01/2000
1	Goserelin (Zoladex)FDA Link 01/2000
1	abarelix (Plenaxis)FDA Link 01/2000
1	Hormones (Hormone)IBA 01/2000
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2000
1	Peptides (Polypeptides)IBA 01/2000
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2000

Therapy/Procedure

1	Therapeutics 01/2000
1	Drug Therapy (Chemotherapy) 01/2000
1	Injections 01/2000
1	Prostatectomy (Retropubic Prostatectomy) 01/2000
1	Radiotherapy 01/2000